UBS AM’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Buy |
107,240
+24,438
| +30% | +$277K | ﹤0.01% | 2341 |
|
|
2025
Q1 | $551K | Sell |
82,802
-12,703
| -13% | -$84.5K | ﹤0.01% | 2484 |
|
|
2024
Q4 | $1.05M | Buy |
95,505
+52,813
| +124% | +$583K | ﹤0.01% | 2337 |
|
|
2024
Q3 | $525K | Sell |
42,692
-14,707
| -26% | -$181K | ﹤0.01% | 2632 |
|
|
2024
Q2 | $775K | Buy |
+57,399
| New | +$775K | ﹤0.01% | 2489 |
|
|
2023
Q4 | – | Sell |
-11,398
| Closed | -$44.9K | – | 2600 |
|
|
2023
Q3 | $44.9K | Hold |
11,398
| – | – | ﹤0.01% | 2582 |
|
|
2023
Q2 | $94.9K | Hold |
11,398
| – | – | ﹤0.01% | 2645 |
|
|
2023
Q1 | $94.9K | Buy |
+11,398
| New | +$94.9K | ﹤0.01% | 2645 |
|